secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0001193125-23-166031
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE receives Nasdaq delisting notice; stock bid price below $0.10 for 10 days
--------------------------------------------------------------------------------

- Nasdaq notified BIOLASE on June 8, 2023 that its common stock had a closing bid price of $0.10 or less for 10 consecutive trading days (May 24 – June 7, 2023).
- Trading suspension and delisting from Nasdaq Capital Market set for June 20, 2023, unless a hearing is requested.
- Company plans to timely request a hearing before the Nasdaq Hearings Panel to stay the suspension pending a decision.
- Previous deficiency notice on January 11, 2023 for bid price below $1.00; 180-day grace period expires July 10, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000119312523166031/0001193125-23-166031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000119312523166031/d493860d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-166031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer